Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience, Inc. (AIFF) is a Software - Application company in the Technology sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $16M; returns 1 day -9.8%, 1 week -9.8%, 1 year -55.1%.

Firefly Neuroscience, Inc. (AIFF) is a commercial-stage medical technology firm specializing in artificial intelligence and neuroscientific solutions. The company’s primary value driver is its proprietary Brain Network Analytics (BNA) platform, an FDA-cleared software-as-a-medical-device (SaMD) that utilizes electroencephalogram (EEG) data to objectively measure brain health.

Groups AIFF belongs to

• Artificial Intelligence
• Healthcare Technology
• Medical Devices
• Neuroscience
• Commercial Stage
• Healthcare IT
• Software
• AI in Healthcare
• Health Diagnostics and Imaging
• SaaS
• Data Analytics
• CNS Disorders
• Healthcare Innovation

AIFF financial model: income statement, cash flow and balance sheet